Hassanin, M.A.; Mustafa, M.; Abourehab, M.A.S.; Hassan, H.A.; Aly, O.M.; Beshr, E.A.M.
Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857.
https://doi.org/10.3390/ph15070857
AMA Style
Hassanin MA, Mustafa M, Abourehab MAS, Hassan HA, Aly OM, Beshr EAM.
Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals. 2022; 15(7):857.
https://doi.org/10.3390/ph15070857
Chicago/Turabian Style
Hassanin, Moamen A., Muhamad Mustafa, Mohammed A. S. Abourehab, Heba A. Hassan, Omar M. Aly, and Eman A. M. Beshr.
2022. "Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations" Pharmaceuticals 15, no. 7: 857.
https://doi.org/10.3390/ph15070857
APA Style
Hassanin, M. A., Mustafa, M., Abourehab, M. A. S., Hassan, H. A., Aly, O. M., & Beshr, E. A. M.
(2022). Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals, 15(7), 857.
https://doi.org/10.3390/ph15070857